ZafirlukastiscommonlyrecognizedasaleukotrienereceptorantagoNISTwhichisusedinthetreatmentofasthma.ItisfoundtobeapotentinhibitorofVEGF-C/Nrp2.Researchontopicalusagesuggeststhatzafirlukastmayalsobeeffectiveinpreventingcapsularcontractureandreducingcapsuleformationofgelimplants,acomplicationarisingafterbreastimplantsurgery.
| CasNo. | 107753-78-6 |
|---|---|
| Purity | ≥98% |
| Formula | C31H33N3O6S |
| FormulaWt. | 575.68 |
| IUPACName | Cyclopentyl[3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-1H-indol-5-yl]carbamate |
| MeltingPoint | 138-140°C |
| Solubility | SolubleinDMSO(25mg/ml). |
| Appearance | Whitetopinkpowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | Z0222InfoSheetPDF |
|---|
OdaS,FijiwaraR,KutsunoY,etal.TargetedscreenforhumanUDP-glucuronosyltransferasesinhibitorsandtheevaluationofpotentialdrug-druginteractionswithzafirlukast.DrugMetalDispos.2015Jun;43(6):812-818.PMID:25834030.
BandaruS,MarriVK,KaseraP,etal.Structurebasedvirtualscreeningofligandstoidentifycysteinylleukotrienereceptor1antagonist.Bioinformation.2014Oct30;10(10):652-657.PMID:25489175.
KangSH,ShinKC,KimWS,etal.Thepreventiveeffectoftopicalzafirlukastinstillationforperi-implantcapsuleformationinrabbits.ArchPlastSurg.2015Mar;42(2):179-185.PMID:25798389.
